GLP-1 Annual Cost Calculator: The Real 12-Month Price Tag
Price verification — October 26, 2026
This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
- Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
- Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
- Sesame annual-commitment terms: Official source.
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
GLP-1 treatment is not a one-month commitment. Most clinicians recommend 12–18 months minimum, and many patients continue indefinitely. Understanding the full annual cost — not just the first-month price — is critical for budgeting.
Why the first month is misleading
Providers like Embody offer a compelling $149 first month, but the ongoing cost is $299/month. Over 12 months, that's $3,439 — not the $1,788 you'd calculate from the advertised price. In contrast, flat-pricing providers like GobyMeds ($99/mo) and Gala ($179/mo) charge the same amount every month regardless of dose.
12-month cost by provider (semaglutide)
| Provider | Mo 1 | Mo 2–12 | 12-Mo Total |
|---|---|---|---|
| GobyMeds | $99 | $99 | $1,188 |
| Get Thin MD | $119 | $119 | $1,428 |
| BiltRx | $125 | $125 | $1,500 |
| Oak | $130 | $130 | $1,560 |
| Sunlight | $159 | $179 | $2,128 |
| Gala | $179 | $179 | $2,148 |
| Tonik | $248 | $248 | $2,976 |
| Embody | $149 | $299 | $3,438 |
The annual cost difference between the cheapest option (GobyMeds at $1,188) and a provider with dose-based pricing (Embody at $3,438) is $2,250 per year — for the same active ingredient.
Multi-year projections
For patients on maintenance therapy, the savings compound dramatically. Over 3 years at GobyMeds ($99/mo) vs a $299/mo provider, the cumulative savings exceed $7,200. At 5 years, it's over $12,000.
HSA/FSA eligibility
GLP-1 medications prescribed for a medical indication (obesity with BMI ≥30, or BMI ≥27 with a weight-related comorbidity) typically qualify for HSA and FSA spending. This effectively gives you a tax discount of 22–37% depending on your bracket. Embody specifically advertises HSA/FSA acceptance. Check with your plan administrator for specific eligibility.
⚕️ FDA Notice: Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies using FDA-approved active ingredients but are not individually reviewed by the FDA for safety, effectiveness, or quality. Always consult a licensed clinician before starting any GLP-1 therapy.
$1,188 per year. That's it.
GobyMeds: $99/mo × 12 months. Code x7X72r for $25 off your first order.
Start for $99/mo →